BUDGET SILO MENTALITY BEHIND THE FORMER IRON CURTAIN- A CASE STUDY FROM HUNGARY

Author(s)

Imre Boncz, MD, MSc, PhD, department head1, László Gulácsi, PhD, Associate Professor2, Andor Sebestyén, MD, MBA, deputy director31University of Pécs, Pécs, Hungary; 2 Corvinus University of Budapest, Budapest, Hungary; 3 National Health Insurance Fund Administration, Pécs, Hungary

OBJECTIVES: Between 1994-2006 the budget for pharmaceutical reimbursement of the Hungarian National Health Insurance Fund Administration (OEP), the only health care financing agency in Hungary, showed significant deficit. It means that the actual drug expenditures became much higher at the end of the year as it was originally planned at the beginning of the fiscal year. The aim of the study to analyse the drug budget of the OEP by identifying the pattern of this deficit. METHODS: Data derived from the financial database of the Hungarian National Health Insurance Fund Administration, covering the period 1994-2006. We analysed the planned and the actual drug budget focusing on the deficit. Deficit was calculated as follows: dividing the gap between the planned and the actual budget by the actual budget. RESULTS: In each year between 1994-2006 we found a deficit at the drug budget of the OEP. This deficit varied between 2.8 % (lowest, 1996) and 36.6 % (highest, 2006) of total actual expenditures. We found 4 peaks on the diagram showing the deficit in the following years: 1994 (21.5 %), 1998 (32.1 %), 2002 (36.6 %) and 2006 (30.4 %). In each of these years, both national governmental and local elections were held in Hungary. CONCLUSION: We found deficit in the drug budget of the Hungarian OEP in each year between 1994-2006, however the highest deficit occurred in those years with political elections. Such strong coincidence between political elections and drug budget should be omitted as soon as possible in order to provide a more transparent way of drug reimbursement policy.

Conference/Value in Health Info

2007-10, ISPOR Europe 2007, Dublin, Ireland

Value in Health, Vol. 10, No. 6 (November/December 2007)

Code

PHP3

Topic

Health Policy & Regulatory

Topic Subcategory

Pricing Policy & Schemes

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×